This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: VOLGA Trial - ctDNA Clearance in Cisplatin-Ineligible MIBC With Durvalumab + Tremelimumab + Enfortumab Vedotin

51 views
September 23, 2024
Comments 0
Login to view comments. Click here to Login